Today, SBC is home to more than 45 pioneering businesses working across areas including cell and gene therapy, AI-enabled drug discovery, neuroscience, diagnostics and precision medicine. By bringing together entrepreneurs, scientists, investors and industry partners, the campus helps accelerate the translation of world-class science into life-improving medicines and technologies for patients.
Professor Jackie Hunter, Chair of the SBC Board, said:
“It is good news for the economy and life sciences R&D that GSK are continuing to invest the UK. Since it was created in 2012 the Stevenage Bioscience Catalyst has created a strong ecosystem where companies based here have raised more than £4 billion in investment over the past decade.
With more than 45 pioneering companies on campus, we have great confidence in the future of the cluster and will continue to support our collaborative community here. We are also working closely with colleagues in Cambridge, London and beyond to accelerate life science innovation and will grow and build these partnerships to the benefit of our companies and the region.”
Andrew Waters, Interim CEO of SBC, added:
“Our thoughts are with everyone affected by GSK’s announcement, and we recognise this will be an uncertain time for many colleagues and their families.
Our focus remains on supporting the outstanding companies based here in Stevenage and helping them start, grow and succeed. The strength of SBC has always been its collaborative community, bringing together entrepreneurs, scientists, investors, industry partners and mentors to help innovative businesses accelerate their journey from discovery to patient impact.
We will continue to strengthen those connections across the Golden Triangle and beyond, creating opportunities for collaboration, investment and growth for the companies that call SBC home. We will also continue to do this with drive and passion in order to further develop the dynamic, creative and inspiring environment in which scientists can perform their best work.”
Cllr Richard Henry, Lead of Stevenage Borough Council, said:
“Stevenage has built a thriving life sciences ecosystem and remains a key location for innovation, investment and high-value employment.
As the town continues its £1 billion regeneration programme, we look forward to continuing our close partnership with Stevenage Bioscience Catalyst, businesses and academic partners to strengthen Stevenage’s position at the heart of the UK’s life sciences Golden Triangle.”
